The Functional Food and Drinks Market Was Worth $26.4bn in Europe and the US in 2005, It Continues To Grow At A CAGR Of 4.4%
DUBLIN, Ireland--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/reports/c48234) has announced the addition of Next-Generation Nutraceuticals - Food and pharma convergence in disease prevention and personalized nutrition to their offering.
Today, consumers are taking a more proactive approach to managing their health and the prevention of diet-related diseases, such as obesity, diabetes, cardiovascular and bone and joint diseases. Many of these diseases are at epidemic levels, and this combined with increasing patient power makes the prevention of these lifestyle diseases attractive markets for both the food and pharmaceutical industries to exploit.
Next-Generation Nutraceuticals is a new report published by Business Insights that provides analysis of how the food and pharmaceutical industries are becoming more aligned in their approach to consumer health. This report assesses the changing regulatory landscape in addition to how the strategies of leading ingredients, food, drinks and pharmaceutical companies are evolving in the new consumer health marketplace.
Understand how food and drinks manufacturers are applying genomic and proteomic technologies that are widely used in the pharmaceutical industry in order to create increasingly sophisticated functional food products with this new report.
Some key findings from this report...
- The functional food and drinks market was worth $26.4bn in Europe and the US in 2005. It continues to grow at a CAGR of 4.4%, driven by consumers' increasing acceptance of functional foods and a desire to self-medicate.
- The food and drinks industry is adopting pharma technologies in order to create more sophisticated and personalized health products. These technologies include genomics, transcriptomics, metabolomics and nanotechnology.
- Labelling and health claim regulations are likely to change globally as a result of the evolution of functional food and drinks. These changes are likely to include issues such as harmonization of regulatory guidelines and more extensive clinical trials.
- A major growth area for Nestlé is heart health. In 2004, of all the functional products launched by the company, only 6.5% were heart health products, but this share increased to 29.7% in 2006.
Your questions answered...
- In what ways are the food and pharma industries converging?
- How are the food and pharma industries tackling the prevention of lifestyle related health problems including obesity, diabetes and cardiovascular disease?
- How are functional food and drinks evolving to have qualities associated with pharma products?
- How are food and drinks companies applying the use of pharma technologies?
- How will regulatory changes affect the future of functional foods and drinks globally?
- Which companies are the leading innovators in nutrigenomics and with whom are they partnering?
This new report will enable you to...
- Assess changing cross-market dynamics using this report’s analysis of convergence between companies including Chr. Hansen and BASF and the pharmaceutical industry and the innovative functional ingredients that this produces.
- Understand how nutrigenomics will revolutionize the functional food and drinks market through enabling a more personalized approach to the management of diet and health, mirroring pharmacogenomic and personalized medicine developments in the pharmaceutical industry.
- Identify the opportunities and threats resulting from regulatory changes regarding health claims on food and drinks in Europe, the US and Japan, and the prospect of a closer alignment with pharmaceutical regulation in the development of the next generation of functional food and drink products.
- Predict future food and pharma product developments using the report's critical evaluation of recent partnering activity between leading food and drinks companies and innovative biotechnology platform developers.
Food and pharmaceutical disease prevention
Functional food and drinks
Technologies for nutrigenomics
The regulatory landscape
Strategies of leading ingredient, food, drinks and pharma companies
Future challenges and opportunities
List of Figures
List of Tables
- Sciona Inc
- WellGen Inc
- Chr. Hansen
For more information visit http://www.researchandmarkets.com/reports/c48234
Source: Business Insights